Effects of maternal medication on long-term outcome in congenital heart block remain to be established. Response to: 'Comorbidity and long-term outcome in patients with congenital heart block and their siblings exposed to Ro/SSA autoantibodies in utero' by Satis et al

Ann Rheum Dis. 2020 Aug;79(8):e95. doi: 10.1136/annrheumdis-2019-215677. Epub 2019 Jul 4.
No abstract available

Keywords: autoantibodies; autoimmune diseases; cardiovascular disease.

Publication types

  • Comment

MeSH terms

  • Antibodies, Antinuclear
  • Autoantibodies*
  • Comorbidity
  • Heart Block / congenital
  • Humans
  • Siblings*

Substances

  • Antibodies, Antinuclear
  • Autoantibodies

Supplementary concepts

  • Congenital heart block